Atlanta, GA (March 4, 2019) – MSouth Equity Partners, an Atlanta-based private equity firm, announced the closing of its newest investment.  In partnership with the company’s Co-Founders, MSouth completed the acquisition of Catalyst.

The Company, headquartered in Alpharetta, GA, is a leading contract manufacturer of dietary and nutrition supplements. The company delivers high service levels across the value chain to small to large-sized supplements brands primarily in the sports nutrition, herbal and vitamin product categories. In addition to traditional manufacturing, Catalyst also provides services such as custom formulation and proprietary flavoring, creating strategic relationships with its customers.

Dan Campbell, an MSouth Partner, said, “We are very excited to be partnering with Brett Anderson and Dustin DePanicis (Catalyst’s Co-Founders) and their team in the Company’s next phase of growth. In a short period of time, Catalyst has created a unique platform that provides differentiated services to growing supplements companies. Catalyst is known by its customers for superior customer service, lead times, quality, and category expertise. Catalyst is well positioned to capitalize on the growing and fragmented supplements contract manufacturing industry.”

MSouth Equity Partners is a private equity investment firm that provides equity capital and expertise to support management teams in acquisitions and recapitalizations of lower middle market companies typically valued between $25 and $200 million. Based in Atlanta, Georgia, MSouth invests primarily in the South with a consistent focus on management buyouts of business services, specialty distribution, niche manufacturing, healthcare services and telecommunications/media companies. With over $2.2 billion under management across four funds, MSouth is a successor to Cravey, Green & Wahlen, Inc., which was founded in 1984.